Search

everythinglearnresearchcommunity

for

Search:↓

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Finger length ratios don't predict baldness in men.

The random forest model effectively helps diagnose COVID-19 using key factors like age and symptoms.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Adding obesity data to machine learning models improves heart disease prediction accuracy.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

PCOS causes hormonal issues and infertility, with treatment options including medication and lifestyle changes.

Low testosterone may indicate severe COVID-19 in men.

Scalp Roller therapy helped improve hair growth in patients with hard-to-treat alopecia areata.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Higher leptin levels link to hair loss.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.